Israel Englander Medical Devices

Millennium Management LLC

$192 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$142B	$815 Million 0.43% of portfolio	9,128,728	Q4 2024 Reduced 19.64%
DXCM Dexcom Inc	$27.3B	$239 Million 0.12% of portfolio	3,075,964	Q4 2024 Added 800.34%
ALGN Align Technology Inc	$12.9B	$235 Million 0.12% of portfolio	1,125,862	Q4 2024 Added 50.22%
LIVN Liva Nova PLC	$2.22B	$141 Million 0.07% of portfolio	3,048,686	Q4 2024 Added 3.06%
GMED Globus Medical Inc	$5.52B	$140 Million 0.07% of portfolio	1,694,713	Q4 2024 Added 161.02%
BIO Bio Rad Laboratories, Inc.	$6.41B	$125 Million 0.07% of portfolio	379,077	Q4 2024 Reduced 35.07%
MDT Medtronic PLC	$123B	$124 Million 0.06% of portfolio	1,548,995	Q4 2024 Reduced 75.09%
SNN Smith & Nephew PLC	$12.5B	$84.2 Million 0.04% of portfolio	3,425,765	Q4 2024 New
ABT Abbott Laboratories	$221B	$64.7 Million 0.03% of portfolio	572,109	Q4 2024 Reduced 55.11%
GKOS Glaukos Corp	$4.92B	$59 Million 0.03% of portfolio	393,223	Q4 2024 Added 62.34%
NARI Inari Medical, Inc.	$4.27B	$48.5 Million 0.03% of portfolio	950,510	Q4 2024 Reduced 0.9%
PODD Insulet Corp	$18.1B	$41.3 Million 0.02% of portfolio	158,127	Q4 2024 Reduced 8.43%
RXST Rx Sight, Inc.	$732M	$34.6 Million 0.02% of portfolio	1,007,539	Q4 2024 Added 77.55%
ESTA Establishment Labs Holdings Inc.	$953M	$32.8 Million 0.02% of portfolio	711,691	Q4 2024 Added 172.18%
PACB Pacific Biosciences Of California, Inc.	$279M	$31.2 Million 0.02% of portfolio	17,065,331	Q4 2024 Added 63.73%
SYK Stryker Corp	$142B	$26.5 Million 0.01% of portfolio	73,643	Q4 2024 Added 136.01%
PHG Koninklijke Philips Nv	$23.3B	$24.9 Million 0.01% of portfolio	985,063	Q4 2024 Reduced 2.74%
QTRX Quanterix Corp	$269M	$23.2 Million 0.01% of portfolio	2,185,101	Q4 2024 Added 5.96%
PRCT Procept Bio Robotics Corp	$2.63B	$23.2 Million 0.01% of portfolio	287,847	Q4 2024 Added 427.13%
EW Edwards Lifesciences Corp	$43.5B	$16.9 Million 0.01% of portfolio	228,166	Q4 2024 Reduced 80.0%
ZBH Zimmer Biomet Holdings, Inc.	$23.7B	$14.9 Million 0.01% of portfolio	141,324	Q4 2024 Reduced 19.45%
MXCT Maxcyte, Inc.	$332M	$11.4 Million 0.01% of portfolio	2,740,871	Q4 2024 Reduced 34.63%
TMDX Trans Medics Group, Inc.	$2.15B	$10.3 Million 0.01% of portfolio	164,925	Q4 2024 Added 47.47%
UFPT Ufp Technologies Inc	$1.64B	$10.3 Million 0.01% of portfolio	42,032	Q4 2024 Added 323.33%
VREX Varex Imaging Corp	$512M	$10 Million 0.01% of portfolio	687,997	Q4 2024 Reduced 31.98%
KIDS Orthopediatrics Corp	$571M	$9.8 Million 0.01% of portfolio	422,705	Q4 2024 New
ATEC Alphatec Holdings, Inc.	$1.02B	$9.77 Million 0.01% of portfolio	1,063,923	Q4 2024 Reduced 76.0%
STE Steris PLC	$22.8B	$9.56 Million 0.0% of portfolio	46,521	Q4 2024 Reduced 54.72%
ZIMV Zim Vie Inc.	$314M	$9.24 Million 0.0% of portfolio	656,966	Q4 2024 Reduced 12.33%
NPCE Neuro Pace Inc	$282M	$7.2 Million 0.0% of portfolio	643,211	Q4 2024 Reduced 13.08%
BFLY Butterfly Network, Inc.	$474M	$6.74 Million 0.0% of portfolio	2,160,931	Q4 2024 Added 133.61%
CNMD Conmed Corp	$1.87B	$5.78 Million 0.0% of portfolio	84,388	Q4 2024 Reduced 29.64%
TNDM Tandem Diabetes Care Inc	$1.29B	$5.45 Million 0.0% of portfolio	151,340	Q4 2024 Reduced 89.45%
IRTC I Rhythm Technologies, Inc.	$3.11B	$5.43 Million 0.0% of portfolio	60,217	Q4 2024 Reduced 77.23%
CTKB Cytek Biosciences, Inc.	$587M	$5.22 Million 0.0% of portfolio	803,923	Q4 2024 Added 321.77%
CVRX Cv Rx, Inc.	$242M	$5.13 Million 0.0% of portfolio	405,002	Q4 2024 Reduced 6.93%
SRDX Surmodics Inc	$406M	$4.77 Million 0.0% of portfolio	120,344	Q4 2024 Added 0.42%
AORT Artivion, Inc.	$974M	$4.76 Million 0.0% of portfolio	165,482	Q4 2024 Added 25.12%
CLPT Clear Point Neuro, Inc.	$333M	$4.45 Million 0.0% of portfolio	289,150	Q4 2024 Added 5.04%
CERS Cerus Corp	$257M	$4.43 Million 0.0% of portfolio	2,877,932	Q4 2024 Added 52.14%
BVS Bioventus Inc.	$604M	$3.89 Million 0.0% of portfolio	370,783	Q4 2024 Reduced 14.09%
DCTH Delcath Systems, Inc.	$115M	$3.71 Million 0.0% of portfolio	314,675	Q4 2024 Added 53.42%
FNA Paragon 28, Inc.	$999M	$3.6 Million 0.0% of portfolio	348,306	Q4 2024 New
OFIX Orthofix Medical Inc.	$336M	$2.82 Million 0.0% of portfolio	161,308	Q4 2024 Reduced 17.01%
TCMD Tactile Systems Technology Inc	$272M	$2.79 Million 0.0% of portfolio	163,062	Q4 2024 New
TMCI Treace Medical Concepts, Inc.	$442M	$2.45 Million 0.0% of portfolio	328,773	Q4 2024 Reduced 40.71%
IRMD Iradimed Corp	$655M	$2.42 Million 0.0% of portfolio	44,051	Q4 2024 Reduced 45.09%
INMD In Mode Ltd.	$1.52B	$2.28 Million 0.0% of portfolio	136,316	Q4 2024 Added 35.26%
AXGN Axogen, Inc.	$773M	$2.16 Million 0.0% of portfolio	131,182	Q4 2024 Reduced 86.33%
OM Outset Medical, Inc.	$27.8M	$1.55 Million 0.0% of portfolio	1,393,250	Q4 2024 Reduced 26.22%

Shares Options

Israel Englander

Israel Englander is the founder and CEO of Millennium Management, a successful investment firm that uses technology and data-driven approaches to investing. Englander is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Israel Englander's portfolio

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account